Passive Stretching for Peripheral Arterial Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment for Peripheral Arterial Disease?
Research shows that daily passive stretching of calf muscles can improve blood flow and walking ability in patients with peripheral arterial disease. Additionally, long-term passive stretching has been found to enhance vascular function and reduce arterial stiffness, which are important for cardiovascular health.12345
Is passive stretching safe for humans?
How does passive stretching treatment for Peripheral Arterial Disease differ from other treatments?
Passive stretching is unique because it improves blood flow and reduces arterial stiffness by gently stretching muscles without active movement, which can enhance vascular function and flexibility. Unlike medications or surgical interventions, it is a non-invasive therapy that can be done regularly to improve circulation and muscle elasticity.235910
What is the purpose of this trial?
Peripheral artery disease (PAD) leads to higher mortality rates and strains healthcare systems due to increased costs. It causes leg pain during walking due to reduced blood flow. Nitric oxide (NO) deficiency contributes to vascular issues in PAD, with few effective treatments available. Passive calf muscle stretching boosts NO levels, vascular health, and walking ability in PAD patients. However, the inflammatory processes underlying these improvements are unclear. This study aims to track inflammatory markers and cardiovascular changes during 12 weeks of passive stretching. Additionally, combining stretching with dietary nitrate could further enhance walking capacity by reducing reactive oxygen species. The study will monitor inflammation, vascular function, and oxidative capacity to understand the effects on functional ability in PAD patients. This research is crucial for improving physical function and addressing exercise intolerance in PAD.
Research Team
Jacob T Caldwell, Ph.D.
Principal Investigator
Assistant Professor
Eligibility Criteria
This trial is for individuals with Peripheral Arterial Disease (PAD), which causes leg pain and difficulty walking due to poor blood flow. Participants should be interested in exploring non-drug treatments like stretching and dietary changes to improve their condition.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo passive stretching of the calf muscles 5 days per week for 12 weeks, combined with dietary nitrate to enhance walking capacity
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of functional capacity, inflammatory markers, and vascular function
Treatment Details
Interventions
- Dietary Nitrate
- Passive Stretching
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, La Crosse
Lead Sponsor